A Pan-Canadian, Retrospective Evaluation of MitraClip Safety and Efficacy
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Mitral Regurgitation
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Retrospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
In addition to evaluating efficacy and safety, PREMISE will include a description of patient demographics, etiology of mitral regurgitation, co-morbidities, medication use and functional class. It will also compare re-hospitalization for heart failure 12 months prior and 12 months after the procedur...
In addition to evaluating efficacy and safety, PREMISE will include a description of patient demographics, etiology of mitral regurgitation, co-morbidities, medication use and functional class. It will also compare re-hospitalization for heart failure 12 months prior and 12 months after the procedure.
Tracking Information
- NCT #
- NCT03592043
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Shamir Mehta, MD MSc FRCPC Population Health Research Institute; McMaster University Principal Investigator: Neil Fam, MD MSc FRCPC St. Michael's Hospital, University of Toronto